Investing in the next wave of Immuno-oncology

We are unlocking the broader possibilities of immuno-oncology, taking cancer on through the power of the body’s immune system.

PRESS RELEASE 14 May 2020 at 14:00

Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-oncology Portfolio

Read more on Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-oncology Portfolio
PRESS RELEASE 27 Feb 2020 at 16:00

Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform

Read more on Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform
Oncology

Research in Immuno-Oncology

Dr. Jonathon Sedgwick explains the ways in which immuno-oncological drugs enable the immune system to fight cancer.

Watch the video on Research in Immuno-Oncology
Working Together in Oncology

Science Focus

Oncology & Cancer Immunology

Read more on Oncology & Cancer Immunology